FIGURE 1.

Changes in body temperature after hospitalization/administration of casirivimab and imdevimab (CAS/IMB). Panels (a) and (b) show time‐dependent changes in body temperature in the CAS/IMB and non‐CAS/IMB groups, respectively. In the CAS/IMB group, a transient increase in body temperature was observed 8 h after drug administration; thereafter, the body temperature decreased, and no significant difference was observed. In the non‐CAS/IMB group, there was a significant increase in body temperature at 24 and 48 h compared with that at the time of admission. In the intergroup comparison, a significantly lower body temperature was reported in the CAS/IMB group at 24 and 48 h after administration/hospitalization than that in the non‐CAS/IMB group.